期刊文献+
共找到235篇文章
< 1 2 12 >
每页显示 20 50 100
Prevalence of Anti-endothelial Cell Antibodies in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases 被引量:7
1
作者 Meng-tao Li Jun Ai +4 位作者 Zhuang Tian Quan Fang Wen-jie Zheng Xue-jun Zeng Xiao-feng Zeng 《Chinese Medical Sciences Journal》 CAS CSCD 2010年第1期27-31,共5页
Objective To investigate the prevalence of anti-endothelial cell antibodies (AECAs) in the sera of connective tissue diseases (CTD) patients with pulmonary arterial hypertension (PAH) and its correlation with clinical... Objective To investigate the prevalence of anti-endothelial cell antibodies (AECAs) in the sera of connective tissue diseases (CTD) patients with pulmonary arterial hypertension (PAH) and its correlation with clinical manifestations. Methods AECAs in sera of 39 CTD patients with PAH,22 CTD patients without PAH,and 10 healthy donors as controls were detected with Western blotting. The prevalence of different AECAs in different groups was compared and its correlation with clinical manifestations was also investigated. Results The prevalence of AECAs was 82.1% in CTD patients with PAH,72.7% in CTD patients without PAH,and 20.0% in healthy donors. Anti-22 kD AECA was only detected in CTD patients with PAH (15.4%). Anti-75 kD AECA was more frequently detected in CTD patients with PAH than in those without PAH (51.3% vs. 22.7%,P<0.05). In CTD patients with PAH,anti-75 kD AECA was more frequently detected in those with Raynaud’s phenomenon or with positive anti-RNP antibody. Conclusion AECAs could be frequently detected in CTD patients with or without PAH,while anti-22 kD and anti-75 kD AECA might be specific in CTD patients with PAH. 展开更多
关键词 connective tissue diseases pulmonary arterial hypertension anti-endothelial cell antibodies
在线阅读 下载PDF
Induction of Endothelial Cell Apoptosis by Anti-alpha-enolase Antibody 被引量:3
2
作者 Hong-bo Yang Wen-jie Zheng +1 位作者 Xuan Zhang Fu-lin Tang 《Chinese Medical Sciences Journal》 CAS CSCD 2011年第3期152-157,共6页
Objective To assess the prevalence of anti-alpha-enolase antibody in systemic autoimmune diseases in Chinese patients and its role in endothelial cell apoptosis.Methods The reactivity of anti-alpha-enolase antibody in... Objective To assess the prevalence of anti-alpha-enolase antibody in systemic autoimmune diseases in Chinese patients and its role in endothelial cell apoptosis.Methods The reactivity of anti-alpha-enolase antibody in a variety of autoimmune disorders in Chinese patients was evaluated by dot blot assay.Endothelial cell apoptosis was investigated by in vitro incubation of endothelial cells with IgG purified from anti-alpha-enolase antibody-positive sera,with or without pre-incubation with recombinant alpha-enolase.Results Anti-alpha-enolase antibody was prevalent in different systemic autoimmune diseases with relatively high reactivity in Chinese patients.In vitro incubation of endothelial cells with IgG containing anti-alpha-enolase antibody induced apoptosis in a time-and dose-dependent manner.Apoptosis was partly inhibited by pre-incubation of the endothelial cells with recombinant alpha-enolase.Conclusions Our data suggest that alpha-enolase is a common auto-antigen recognized by anti-endothelial cell antibodies in connective tissue disease.Interaction between alpha-enolase and its autoantibody plays a role in endothelial cell apoptosis.Changes other than cell killing may contribute to the pathogenesis of endothelial damage and microvascular lesions. 展开更多
关键词 anti-alpha-enolase antibody apoptosis endothelial cell
在线阅读 下载PDF
Polyclonal antibody production and expression of CREG protein in human vascular smooth muscle cells
3
作者 Yaling HAN Haiwei LIU Jian KANG Xiaozeng WANG Ye HU Lianyou ZHAO Shaohua LI 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2005年第2期118-122,共5页
Objectives The cellular repressor of E1A-activated genes (CREG), a novel gene, was recently found to play a role in inhibiting cell growth and promoting cell differentiation. The purpose of this study was to obtain an... Objectives The cellular repressor of E1A-activated genes (CREG), a novel gene, was recently found to play a role in inhibiting cell growth and promoting cell differentiation. The purpose of this study was to obtain antibody against CREG protein and to study the expression of CREG protein in human internal thoracic artery cells (HITASY) which express different patterns of differentiation markers after serum withdrawal. Methods The open reading frame of CREG gene sequence was amplified by PCR and cloned into the pGEX-4T-1 vector. Glutathione-S-transferase (GST)-CREG fusion protein was expressed in E. Coli BL21 and purified from inclusion bodies by Sephacryl S-200 chromatography. Rabbits were immunized with the purified GST-CREG protein. Western blot examined with immunohistochemistry staining and the protein expression level was analyzed by Western blot in HITASY cells after serum removal. Results It was confirmed by using endonuclease digesting and DNA sequencing that the PCR product of CREG was correctly inserted into the vector. The GST-CREG protein was purified with gel filtration chromatography. Polyclonal antibody against GST-CREG was obtained from rabbits. CREG protein immunohistochemistry staining displayed a perinuclear distribution in the cytoplasm of HITASY cells. Results from Western blot suggested that comparing with the untreated cells upregulation of CREG polyclonal antibody against CREG was comfirmed. Using this antibody, the changes of CREG protein expression was observed in the process of phenotypic modulation of HITASY cells. These results provide basic understanding on the relationship of CREG gene with the cell phenotypic conversion. 展开更多
关键词 E1A cellular REPRESSOR POLYCLONAL antibody VASCULAR smooth muscle cells differentiation
在线阅读 下载PDF
Establishment of anti-thyrotropin monoclonal antibody hybridoma cell lines with extract of human pituitary gland
4
作者 姬秋和 罗敏 +2 位作者 谢晓雁 许曼音 陈家伦 《Journal of Medical Colleges of PLA(China)》 CAS 1997年第3期210-213,共4页
To get the hybridoma cell lines secreting anti-thyrotropin monoclonal antibodies with high affinity and specificity. Methods: BALB/c mice were immunized with extract of human pituitaries. The spleen cells of one immun... To get the hybridoma cell lines secreting anti-thyrotropin monoclonal antibodies with high affinity and specificity. Methods: BALB/c mice were immunized with extract of human pituitaries. The spleen cells of one immunized mouse were fused with mouse myeloma cells in polyethylene glycol and the positive clones were subcloned 3 times. Results: Two hybridoma cell lines which secrete anti-thyrotropin monoclonal antibodies with high affinity and specificity have been collected. The antibodies were of the IgG1 subclass and their maximum binding with thyrotropin was 60% and 45. 1% respectively. Using competitive binding assay,the antibodies were found to direct against different epitopes of human thyrotropin. Conclusion: The extract of human pituitaries could be used to produce monoclonal anti-pituitary hormone antibodies. The two anti-thyrotropin monoclonal antibodies produced in this study could be used in the establishment of a sensitive measurement of human thyrotropin. 展开更多
关键词 MONOCLONAL antibody THYROTROPIN HYBRIDOMA cell lines
在线阅读 下载PDF
PD-L1单抗加强紫杉醇联合香菇多糖体外抗人乳腺癌MDA-MB-231作用
5
作者 李汾 平娜娜 +2 位作者 曾菊绒 胥晓丽 刘鹏 《西安交通大学学报(医学版)》 北大核心 2025年第1期94-100,共7页
目的 探讨程序性细胞死亡-配体1(PD-L1)单抗、紫杉醇(PTX)联合香菇多糖(LNT)体外对人乳腺癌细胞(MDA-MB-231)的作用。方法 将MDA-MB-231、人外周血单个核细胞(PBMC)和MDA-MB-231+PBMC共培养,随机分为对照组、PTX组、LNT组、MPDL3280A(PD... 目的 探讨程序性细胞死亡-配体1(PD-L1)单抗、紫杉醇(PTX)联合香菇多糖(LNT)体外对人乳腺癌细胞(MDA-MB-231)的作用。方法 将MDA-MB-231、人外周血单个核细胞(PBMC)和MDA-MB-231+PBMC共培养,随机分为对照组、PTX组、LNT组、MPDL3280A(PD-L1单抗)组、PTX+LNT组和PTX+LNT+MPDL3280A组。采用CCK8检测细胞的活性;流式细胞术检测MHC-I和PD-L1的表达;ELISA试剂盒检测IFN-γ和TNF-α的含量。结果 与对照组相比,PTX组、MPDL3280A组、PTX+LNT组及PTX+LNT+MPDL3280A组显著抑制MDA-MB-231的活性(P<0.01);LNT组和PTX+LNT+MPDL3280A组显著促进PBMC的免疫作用(P<0.05,P<0.01);PTX+LNT+MPDL3280A组显著抑制MDA-MB-231+PBMC共培养MDA-MB-231的活性(0.56±0.16 vs. 0.39±0.13,P<0.05);LNT显著促进MDA-MB-231上PD-L1的表达和PBMC分泌IFN-γ(P<0.05)。结论 PD-L1单抗通过阻断PD-L1与PD-1之间的作用,提高免疫,促进PTX联合LNT的体外抗三阴性乳腺癌作用。 展开更多
关键词 程序性细胞死亡-配体1(PD-L1)单抗 紫杉醇(PTX) 香菇多糖(LNT) 抗人乳腺癌MDA-MB-231
在线阅读 下载PDF
SF3B1/FOXM1/JUNB轴调控SOX21表达对宫颈癌细胞生物学行为的影响研究
6
作者 高洁 阿依努尔·色义提 +2 位作者 谢丽 夏依拉·艾合买提 侯友翔 《成都医学院学报》 2025年第1期1-5,10,共6页
目的分析剪接因子3B亚基1/叉头框转录因子M1/转录因子活化蛋白激酶B(SF3B1/FOXM1/JUNB)轴调控转录因子21抗体(SOX21)表达对宫颈癌细胞生物学行为的影响。方法选取2022年3月至2023年12月新疆医科大学附属肿瘤医院收治的50例宫颈癌患者的... 目的分析剪接因子3B亚基1/叉头框转录因子M1/转录因子活化蛋白激酶B(SF3B1/FOXM1/JUNB)轴调控转录因子21抗体(SOX21)表达对宫颈癌细胞生物学行为的影响。方法选取2022年3月至2023年12月新疆医科大学附属肿瘤医院收治的50例宫颈癌患者的癌旁组织及癌组织作为研究对象,利用实时荧光定量PCR检测SF3B1、FOXM1、JUNB、SOX21表达;通过Transwell、细胞计数试剂8(CCK8)检测宫颈癌细胞生物学行为(增殖、迁移、侵袭);利用蛋白质印迹法测定SF3B1、FOXM1、JUNB、SOX21蛋白表达。结果与癌旁组织相比,宫颈癌组织JUNB表达低,FOXM1、SOX21、SF3B1表达高,差异有统计学意义(P<0.05);与si-NC组相比,si-SF3B1/FOXM1/JUNB组0 h OD450值高,侵袭细胞数、迁移细胞数、(24、48 h)OD450值、SF3B1、FOXM1、JUNB低,差异有统计学意义(P<0.05);与OE-NC组相比,OE-SOX21组迁移细胞数、(0、24、48 h)OD450值、SOX21、侵袭细胞数高,差异有统计学意义(P<0.05);与si-SF3B1/FOXM1/JUNB+OE-NC组相比,si-SF3B1/FOXM1/JUNB+OE-SOX21组SOX21、SF3B1、FOXM1、JUNB、(0、24、48 h)OD450值、侵袭细胞数、迁移细胞数高,差异有统计学意义(P<0.05)。结论SF3B1/FOXM1/JUNB轴通过激活SOX21表达可促进宫颈癌细胞侵袭、增殖、迁移。 展开更多
关键词 剪接因子3B亚基1/叉头框转录因子M1/转录因子活化蛋白激酶B 转录因子21抗体 宫颈癌细胞 迁移 侵袭 增殖
在线阅读 下载PDF
肺癌新型治疗方法:机会与挑战
7
作者 李安娜 江本元 +3 位作者 徐崇锐 杨学宁 杨衿记 吴一龙 《循证医学》 2025年第1期1-18,共18页
前言根据最新的癌症统计,肺癌依然是最常见的致命肿瘤,新发病例及死亡率均居首位[1,2];驱动基因阳性如表皮生长因子受体(epidermal growth factor receptor,EGFR)[3]、棘皮动物微管相关蛋白样4-间变性淋巴瘤激酶(echinoderm microtubule... 前言根据最新的癌症统计,肺癌依然是最常见的致命肿瘤,新发病例及死亡率均居首位[1,2];驱动基因阳性如表皮生长因子受体(epidermal growth factor receptor,EGFR)[3]、棘皮动物微管相关蛋白样4-间变性淋巴瘤激酶(echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase,EML4-ALK)、ROS1(C-ros oncogene 1)等受益于靶向抑制剂的使用而发生了巨大进步[4];在接受靶向治疗后,平均中位生存期提高到20~30个月[5,6]。 展开更多
关键词 非小细胞肺癌 抗体偶联药物 特异性抗体 新型疗法
在线阅读 下载PDF
双特异性抗体-抗体偶联药物可能成为晚期NSCLC患者的潜在治疗选择
8
作者 刘雨桃 《循证医学》 2025年第1期31-31,共1页
抗体偶联药物(antibody-drug conjugate,ADC)在实体肿瘤治疗领域已取得突破性进展,其通过“靶向递送-精准杀伤”机制实现治疗窗口的显著拓展。BL-B01D1是首个针对表皮生长因子受体(epidermal growth factor receptor,EGFR)和人表皮生长... 抗体偶联药物(antibody-drug conjugate,ADC)在实体肿瘤治疗领域已取得突破性进展,其通过“靶向递送-精准杀伤”机制实现治疗窗口的显著拓展。BL-B01D1是首个针对表皮生长因子受体(epidermal growth factor receptor,EGFR)和人表皮生长因子受体3(human epidermal growth factor receptor 3,HER3)的双特异性抗体-抗体偶联药物,此项研究报道BL-B01D01在局部晚期或转移性实体肿瘤患者中显示出初步抗肿瘤活性及临床可接受的安全性[1]。 展开更多
关键词 抗体偶联药物 非小细胞肺癌
在线阅读 下载PDF
转铁蛋白受体单克隆抗体纳米载药系统在白血病靶向治疗中的应用研究
9
作者 韩海娜 王敏阁 《中国医学工程》 2025年第2期54-58,共5页
目的 观察转铁蛋白受体单克隆抗体(TfR mAb)纳米载药系统辅助靶向治疗白血病的临床效果。方法 该次研究为前瞻性研究,选取2020年5月至2022年12月期间商丘市第一人民医院收治的白血病患者中随机抽取85例,分组方式为电脑随机分组法,将入... 目的 观察转铁蛋白受体单克隆抗体(TfR mAb)纳米载药系统辅助靶向治疗白血病的临床效果。方法 该次研究为前瞻性研究,选取2020年5月至2022年12月期间商丘市第一人民医院收治的白血病患者中随机抽取85例,分组方式为电脑随机分组法,将入组患者分别列为靶向组(42例)和联合组(43例),两组患者均接受靶向治疗,联合组采用TfR mAb纳米载药系统辅助靶向治疗,所有患者开展为期1年随访,比较两组患者的近期疗效及短期预后情况。结果 在不同治疗方案下,联合组治疗7 d、14 d、21 d后的人早幼粒白血病细胞(HL-60)凋亡率分别为(20.45±5.18)%、(23.36±5.47)%、(26.33±5.45)%,均高于靶向组[(18.45±3.23)%、(20.47±5.11)%、(23.44±5.23)%](P<0.05);联合组的总缓解率[86.05%(37/43)]高于靶向组[66.67%(28/42)](P<0.05);联合组的T淋巴细胞亚群CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)表达水平分别为(65.75±10.33)%、(70.24±10.31)%、(1.77±0.26),均高于靶向组[(60.35±10.44)%、(65.22±10.38)%、(1.24±0.72)](P<0.05);随访期间,联合组的中位无进展生存期(PFS)、中位总生存期(OS)分别为(9.36±1.45)个月、(10.41±2.25)个月,均高于靶向组[(8.41±1.25)个月、(9.33±1.72)个月](P<0.05);1年内病情复发率及死亡率分别为6.98%(3/43)、2.33%(1/43),均低于靶向组[28.57%(12/42)、21.43%(9/42)](P<0.05)。结论 TfR mAb纳米载药系统能增强白血病患者的靶向治疗效果,对促进HL-60细胞凋亡、改善机体免疫功能、延长患者生存周期并降低病情复发或死亡风险均有重要意义。 展开更多
关键词 白血病 转铁蛋白受体单克隆抗体 纳米载药系统 细胞凋亡率 预后情况
在线阅读 下载PDF
乳腺癌治疗相关的抗体偶联药物及其耐药机制研究进展
10
作者 潘学强 李笑 +2 位作者 李美霞 李可 姜蕊 《山东医药》 2025年第2期144-148,共5页
乳腺癌已成为全球女性最常见的恶性肿瘤,随病情进展极易发生耐药。抗体偶联药物(ADC)是一种新型靶向生物制剂,通过特异性抗体与细胞毒性有效载荷的结合,精准递送靶向抗原,为乳腺癌的治疗提供了新方向。目前,ADC已逐渐用于乳腺癌的治疗... 乳腺癌已成为全球女性最常见的恶性肿瘤,随病情进展极易发生耐药。抗体偶联药物(ADC)是一种新型靶向生物制剂,通过特异性抗体与细胞毒性有效载荷的结合,精准递送靶向抗原,为乳腺癌的治疗提供了新方向。目前,ADC已逐渐用于乳腺癌的治疗中。根据靶向抗原的不同可将ADC分为靶向人表皮生长因子受体2类ADC、靶向人滋养细胞表面抗原类ADC及其他ADC。乳腺癌治疗相关ADC的耐药机制与ADC抗原表达水平下降、ADC处理过程异常和化疗有效载荷的变化有关。深入研究乳腺癌治疗相关ADC及其耐药机制,可为改善乳腺癌患者的预后提供参考。 展开更多
关键词 抗体偶联药物 人表皮生长因子受体2 人滋养细胞表面抗原 乳腺癌 肿瘤耐药
在线阅读 下载PDF
Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma 被引量:3
11
作者 Yi Fang Jian Hou 《Military Medical Research》 SCIE CSCD 2021年第3期433-443,共11页
Multiple myeloma(MM) is the second most common hematologic malignancy, and is characterized by the clonal expansion of malignant plasma cells. Despite the recent improvement in patient outcome due to the use of novel ... Multiple myeloma(MM) is the second most common hematologic malignancy, and is characterized by the clonal expansion of malignant plasma cells. Despite the recent improvement in patient outcome due to the use of novel therapeutic agents and stem cell transplantation, all patients eventually relapse due to clone evolution. B cell maturation antigen(BCMA) is highly expressed in and specific for MM cells, and has been implicated in the pathogenesis as well as treatment development for MM. In this review, we will summarize representative anti-BCMA immune therapeutic strategies, including BCMA-targeted vaccines, anti-BCMA antibodies and BCMA-targeted CAR cells. Combination of different immunotherapeutic strategies of targeting BCMA, multi-target immune therapeutic strategies, and adding immune modulatory agents to normalize anti-MM immune system in minimal residual disease(MRD) negative patients, will also be discussed. 展开更多
关键词 B cell maturation antigen Multiple myeloma VACCINE antibody CAR T-cells
在线阅读 下载PDF
THE LOCALIZATION OF ADRENOMEDULLIN IN RAT KIDNEY TISSUE AND ITS INHIBITORY EFFECT ON THE GROWTH OF CULTURED RAT MESANGIAL CELLS 被引量:7
12
作者 刘学光 张志刚 +3 位作者 张秀荣 朱虹光 陈琦 郭慕依 《Chinese Medical Sciences Journal》 CAS CSCD 2002年第3期129-133,共5页
OBJECTIVE: To observe the localization of adrenomedullin (AM) in rat kidney tissue and its inhibitory effect on the growth of cultured rat mesangial cells (MsC). METHODS: A monoclonal antibody against AM developed by ... OBJECTIVE: To observe the localization of adrenomedullin (AM) in rat kidney tissue and its inhibitory effect on the growth of cultured rat mesangial cells (MsC). METHODS: A monoclonal antibody against AM developed by our laboratory was used to detect the localization of AM protein in rat kidney tissue by avidin-biotin complex immunohistochemistry. The expressions of AM and its receptor CRLR mRNA on cultured glomerular epithelial cells (GEC) and MsC were investigated by Northern blot assay, and the possible effect of AM secreted by GEC on MsC proliferation was observed using [3H]thymidine incorporation as an index. RESULTS: A specific monoclonal antibody against AM was succesfully developed. AM was immunohistochemically localized mainly in glomeruli (GEC and endothelial cells), some cortical proximal tubules, medullary collecting duct cells, interstitial cells, vascular smooth muscle cells and endothelial cells. Northern blot assay showed that AM mRNA was expressed only on cultured GEC, but not on MsC, however, AM receptor CRLR mRNA was only expressed on MsC. GEC conditioned medium containing AM can inhibit MsC growth and AM receptor blocker CGRP8-37 may partially decreased this inhibitory effect. CONCLUSION: AM produced by GEC inhibits the proliferation of MsC, which suggests that AM as an important regulator is involved in glomerular normal physiological functions and pathologic processes. 展开更多
关键词 ADRENOMEDULLIN monoclonal antibody glomerular epithelial cell glomerular mesangial cell Objective. To observe the localization of adrenomedullin (AM) in rat kidney tissue and its inhibitory effect on the growth of cultured rat mesangial
在线阅读 下载PDF
Understanding neutralising antibodies against SARS-CoV-2 and theirimplications in clinical practice 被引量:1
13
作者 Natalie Yan-Lin Pang Alexander Shao-Rong Pang +1 位作者 Vincent T.Chow De-Yun Wang 《Military Medical Research》 SCIE CSCD 2022年第2期215-230,共16页
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a newly identified member of the coronavirus family that has caused the coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting... Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a newly identified member of the coronavirus family that has caused the coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting SARS-CoV-2has disrupted the lives and livelihoods of millions worldwide. As of 23 August 2021, a total of 211,373,303 COVID-19cases have been confirmed globally with a death toll of 4,424,341. A strong understanding of the infection pathway of SARS-CoV-2, and how our immune system responds to the virus is highly pertinent for guiding the development and improvement of effective treatments. In this review, we discuss the current understanding of neutralising antibodies(NAbs) and their implications in clinical practice. The aspects include the pathophysiology of the immune response,particularly humoral adaptive immunity and the roles of NAbs from B cells in infection clearance. We summarise the onset and persistence of IgA, IgM and IgG antibodies, and we explore their roles in neutralising SARS-CoV-2, their persistence in convalescent individuals, and in reinfection. Furthermore, we also review the applications of neutralising antibodies in the clinical setting—from predictors of disease severity to serological testing to vaccinations, and finally in therapeutics such as convalescent plasma infusion. 展开更多
关键词 Severe acute respiratory syndrome coronavirus Coronavirus disease 2019 Neutralising antibodies PERSISTENCE Spike glycoprotein Receptor-binding domain B cells T cells Convalescent plasma
在线阅读 下载PDF
An immunofluorescence study on the changes of microtubulin in human rectal adenocarcinoma cells killed by LAK cells in vitro
14
作者 丁彦青 张进华 +2 位作者 李春德 王小宁 罗荣城 《Journal of Medical Colleges of PLA(China)》 CAS 1993年第1期34-38,共5页
The human rectal adenocarcinoma cell line(HR8348)was treated withlympholdne activated killer(LAK)cells in vitro and the changes of the microtubulin inboth the effector and target cells were investigated with the aid o... The human rectal adenocarcinoma cell line(HR8348)was treated withlympholdne activated killer(LAK)cells in vitro and the changes of the microtubulin inboth the effector and target cells were investigated with the aid of immunofluorescencemicroscopy.It was revealed that after the attachment of LAK cells to the tumor cells,theeffector-target conjugates formed and distribution of the microtubulin in both the effectorand target cells changed.In the LAK cells,the microtubulin concentrated mainly in thecontact region,forming a crescent-like structure,while in the target cells,themicrotubulin condensed into patches and fused with the crescent-like structure of the LAKcells,Eventually,the target cells degenerated and died.It was suggested that the lysis ofthe target cells may be related to the redistribution of the microtubulin in both theeffector and target cells. 展开更多
关键词 LAK cell RECTAL neoplasms MICROTUBULES fluorescent antibody technic ADENOCARCINOMA HUMAN rats
在线阅读 下载PDF
Effects of tetrodotoxin monoclonal antibody on the blocking action of tetrodotoxin on sodium channels
15
作者 杜爱民 宋杰军 +2 位作者 邢宝仁 沈志超 苗小飞 《Journal of Medical Colleges of PLA(China)》 CAS 1996年第3期184-187,共4页
The effect of tetrodotoxin(TTX) monoclonal antibody (McAb) 8A5 on the blocking action of TTX on sodium channels was studied by using the electrophysiological technique of whole cell recording.We found the specific TTX... The effect of tetrodotoxin(TTX) monoclonal antibody (McAb) 8A5 on the blocking action of TTX on sodium channels was studied by using the electrophysiological technique of whole cell recording.We found the specific TTX McAb have the following characterizations: TTX sensitivity to NG108-15 cell was high , with sodium ion current of NG108-15 cell completely blocked by only 10-6 mol/L level of TTX; when the cell was treated with TTX McAb 8A5 for 1 min and 5min, after the sodium current was completely abolished by TTX, the sodium ion current was restored to 79. 44%?. 20% and 73. 89%?. 74% (n=5) of the control values respectively; when the cell was treated for 1 min with 8A5 and TTX which had been mixed for 1 h before added,the sodium ion current was maintained at 89. 21%?. 41% (n=4) of the control. These results indicated that TTX-induced blockage on the sodium ion current could be powerfully antagonized by TTX McAb 8A5 with two distinct administering ways. 展开更多
关键词 TETRODOTOXIN MONOCLONAL antibody SODIUM CHANNELS whole cell recording
在线阅读 下载PDF
Abnormalities of Cellular Immunoregulation in Patients with Epidemic Hemorrhagic Fever
16
作者 陈龙邦 杨为松 +3 位作者 徐海峰 张文彬 朱平 尚高峰 《Journal of Medical Colleges of PLA(China)》 CAS 1990年第2期106-112,共7页
In this report,a comparative study is made of the function test of spontaneousT suppressor cell(STs)and T Lymphocyte subsets in patients with epidemic hemorrha-gic fever(EHF).It was found that in the early stages ... In this report,a comparative study is made of the function test of spontaneousT suppressor cell(STs)and T Lymphocyte subsets in patients with epidemic hemorrha-gic fever(EHF).It was found that in the early stages of the disease the activity of STs wasmarkedly lower than that of the controls,while the percentage of CD<sub>?</sub><sup>+</sup> cells increasedsignificantly,which led to the decrease and reciprocation of CD<sub>4</sub>/CD<sub>8</sub> ratio,and that theactivity of STs was reversely related to the proportion of CD<sub>8</sub><sup>+</sup> cells on linear regressionanalysis,indicating that the CD<sub>8</sub><sup>+</sup> cells increased may mainly belong to cytotoxic T cells.It was also shown that the changes of STs function and CD<sub>4</sub>/CD<sub>8</sub> ratio were related tothe abnormalities of serum C<sub>3</sub> content and circulating immune complex.The results sug-gest that the disturbance of host cellular immunoregulation may play an important rolein the pathogenesis of EHF. 展开更多
关键词 HEMORRHAGIC fever epidemic immunity cellular T LYMPHOCYTES SUPPRESSOR cells T lymphocytcs cytotoxic antibodies monoclonal
在线阅读 下载PDF
Exact Location of Linear B-cell Epitopes of VP3 Protein of Goose Parvovirus
17
作者 GUO Lu JU Huan-yu YU Tian-fei JING Zhi-qiang MA Bo WANG Jun-wei 《畜牧兽医学报》 CAS CSCD 北大核心 2011年第B12期34-39,共6页
Four monoclonal antibodies (MAbs) against Goose Parvovirus (GPV) VP3 protein already available were used to precisely locate linear B-cell epitopes in VP3 of GPV. The epitopes, recognized by four MAbs, had already bee... Four monoclonal antibodies (MAbs) against Goose Parvovirus (GPV) VP3 protein already available were used to precisely locate linear B-cell epitopes in VP3 of GPV. The epitopes, recognized by four MAbs, had already been identified at low levels of resolution. Complementary oligonucleotides encoding ten amino acid fragments, with five amino acid overlaps were designed with suitable sticky ends for recombination with pET-32a and subsequent expression as small-fragment fusion proteins. Antigenicity of specific oligopeptides was determined by Western blotting with the MAbs. Using the same methods, amino acids were deleted one by one from the peptides of interest, enabling the two epitopes to be precisely located at amino acids 430-435 (-DRIMNP-) and 643-647 (-VFIKN-). 展开更多
关键词 VP3基因 鹅细小病毒 B细胞表位 VP3蛋白 抗原表位 线性 单克隆抗体 位置
在线阅读 下载PDF
Finding an Effective Distance Between T-Cell and B-Cell Using S/W ARQ in an Immune System Communication
18
作者 Sanjit Ningthoujam Tekcham Chingkheinganba Swarnendu K Chakraborty 《China Communications》 SCIE CSCD 2020年第1期174-185,共12页
In this paper,we present the effective distance between T-cell and B-cell in an immune system using Stop and Wait(S/W)Automatic Repeat Request(ARQ).The concentration of the molecules can be increased by increasing the... In this paper,we present the effective distance between T-cell and B-cell in an immune system using Stop and Wait(S/W)Automatic Repeat Request(ARQ).The concentration of the molecules can be increased by increasing the transmitting number of molecules but it may reduce the performance of communication due to higher collision or interference with other molecules.It is also reported in the literature that the concentration of the emitted molecules reduces if the distance from Transmitter(Tx)to Receiver(Rx)increases.Thus,this paper mainly focuses on enhancing the receiver’s capture probability and higher successful complete transmission of the desired molecules by obtaining the effective distance from T-cell to B-cell.In order to find the effective distance,T-cell transmits the molecules 1(Interleukins-2)to B-cell,upon successful reception of molecules 1,antibodies(molecules 2)transmit back to T-cell.Then,the effective distance of an immune system can be obtained after T-cell detects the concentration of the molecules 2 with respect to time.Different schemes of S/W ARQ protocols have implemented in Molecular Communication(MC)but it requires retransmission of duplicate copies due to the lack of addressing an effective distance.Thus,the simulations are performed in MATLAB and the results obtain higher capture probability and also successful complete transmission of the desired molecules. 展开更多
关键词 T-cell B-cell MC ANTIGENS antibodies diffusion coefficient(D) round trip time(RTT)
在线阅读 下载PDF
双重膜滤过式血浆置换联合脱敏治疗单倍体相合造血干细胞移植供者特异性抗体的临床研究
19
作者 王增胜 聂玉玲 +4 位作者 郎涛 张晓燕 蔺思颖 王晓敏 毛敏 《中国血液净化》 CSCD 2024年第1期22-25,共4页
目的探讨分析双重膜滤过式血浆置换(double filtration plasmapheresis,DFPP)联合脱敏治疗单倍体相合造血干细胞移植供者特异性抗体(donor specific antibody,DSA)的疗效。方法采用DFPP联合丙种免疫球蛋白(intravenous immunoglobulin,I... 目的探讨分析双重膜滤过式血浆置换(double filtration plasmapheresis,DFPP)联合脱敏治疗单倍体相合造血干细胞移植供者特异性抗体(donor specific antibody,DSA)的疗效。方法采用DFPP联合丙种免疫球蛋白(intravenous immunoglobulin,IVIG)、利妥昔单抗脱敏治疗DSA阳性患者,检测移植前后DSA水平,主要评估分析其植入情况。结果8例DSA性患者7例获得供者细胞稳定植入,嵌合率均为100%,1例血小板植入不良。经过DFPP、IVIG、利妥昔单抗脱敏处理后为平均荧光强度(mean fluorescence intensity,MFI)(3911±2499),均明显降低,差异均有统计学意义(t=2.101,P<0.001),8例患者中有3例转为弱阳性。干细胞回输第3天复测MFI(907士997),较干细胞回输前再次减低,差异均有统计学意义(t=2.145,P=0.002)。8例患者仅1例发生重度急性移植物抗宿主病。结论双重膜滤过式血浆置换脱敏联合大剂量IVIG和利妥昔单抗,尽量输注高剂量的干细胞,可以降低DSA水平促进供者干细胞植入。 展开更多
关键词 双重膜滤过式血浆置换 供者特异性抗体 单倍体相合造血干细胞移植
在线阅读 下载PDF
THE DEVELOPMENT OF MONOCLONAL ANTIBODY AGAINST rhTNF AND ITS CURATIVE EFFECTSON E.Coli INFECTED MICE
20
作者 郭小清 王爱霞 +1 位作者 陈实平 邱志峰 《Chinese Medical Sciences Journal》 CAS CSCD 1997年第4期229-231,共3页
Fifteen hybridoma cell lines producing monoclonal antiboclies (McAb) against recombinant human tu-mor necrosis factor a (rhTNFa) have been established by fusing SP 2/0 cells with spleen cells from aBALB/c mouse immuni... Fifteen hybridoma cell lines producing monoclonal antiboclies (McAb) against recombinant human tu-mor necrosis factor a (rhTNFa) have been established by fusing SP 2/0 cells with spleen cells from aBALB/c mouse immunized with rhTNFa. Following J M Davis’s Works, semi-solid medium was usedfor initial cloning. Five of them were studied further. Their main chromosome- numbers range were 96 to105, all of them were IgG1 subclass. The affinities of these McAbs were estimated to be 1. 25 ×108 mol/L, 1. 12×108 mol/L, 2. 34×108 mol/L, 8. 55 × 107 mol/L, 1. 04×108 mol/L, respectively.Two groups of mice challenging with E Coli (107 organisms), one group treated with 2mg/kg anti-TNF monoclonal antibody, the other did not. There was a higher survival rate in treated group, the serumTNF level was significantly lower too, and the untreated mice had severe pathologic changes in vlscera. 展开更多
关键词 recombinant human tumor necrosis factor α hybridoma cell monoclonal antibody (McAb )
全文增补中
上一页 1 2 12 下一页 到第
使用帮助 返回顶部